Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

Emanuele Ammatuna*, Matthias Eefting, Kirsten van Lom, François F. Kavelaars, Peter J.M. Valk, Ivo P. Touw

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

29 Citations (Scopus)
4 Downloads (Pure)
Original languageEnglish
Pages (from-to)879-880
Number of pages2
JournalAnnals of Hematology
Issue number5
Publication statusPublished - 1-May-2015
Externally publishedYes

Cite this